Literature DB >> 6958639

The relationship of HLA-B and DR phenotypes to Behcet's syndrome, recurrent oral ulceration and the class of immune complexes.

T Lehner, K I Welsh, J R Batchelor.   

Abstract

A series of eighty Caucasian patients was divided into four groups with the mucocutaneous, arthritic, neurological and ocular types of Behcet's syndrome (BS) and a fifth group of patients with recurrent oral ulcers. The immunogenetic basis of the four types of BS was extended from HLA-B locus to the DR locus. Whereas B5 and more precisely the Bw51 split is the most discriminating marker of the ocular type of BS, DR7 also shows a significant increase in the ocular and neurological types. Indeed, most if not all patients with the ocular type have B5 and/or DR7. B12 and/or DR2 is significantly increased at the less severe end of the spectrum, the mucocutaneous and arthritic types. Patients with recurrent oral ulcers also show an increase in B12 and/or DR2. However, B12 and/or DR7 shows an increase in the relative risk in all four types of BS. These results suggest that HLA-B12, B5, DR7 and DR2 might in some way be associated with tissue localization of disease. Alternatively, since patients with HLA-B12 show a significantly greater ratio of IgG:IgA circulating immune complexes than those with B5/DR7/DR2, tissue localization might be influenced by the immune complex isotype. A significant relationship was also found between the MT2 and MT3 B cell alloantigen system and BS, with particular reference to MT2 and the neurological type and MT3 and the ocular type of BS.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6958639      PMCID: PMC1555564     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Epidemiology of uveitis.

Authors:  E S Perkins
Journal:  Trans Ophthalmol Soc U K       Date:  1976-04

Review 2.  HLA-A, -B and -C antigens, their serology and cross-reaction.

Authors:  V C Joysey; E Wolf
Journal:  Br Med Bull       Date:  1978-09       Impact factor: 4.291

3.  Suppression of human PMN bactericidal activity by human IgA paraproteins.

Authors:  D E Van Epps; K Reed; R C Williams
Journal:  Cell Immunol       Date:  1978-03-15       Impact factor: 4.868

Review 4.  HL-A antigens and disease. Statistical and genetical considerations.

Authors:  A Svejgaard; C Jersild; L S Nielsen; W F Bodmer
Journal:  Tissue Antigens       Date:  1974

5.  HLA-Bw51 and Behçet's disease.

Authors:  S Ohno; T Asanuma; S Sugiura; A Wakisaka; M Aizawa; K Itakura
Journal:  JAMA       Date:  1978-08-11       Impact factor: 56.272

6.  The histocompatibility antigens in patients with Behçet's disease.

Authors:  S Haim; O Gideoni; A Barzilai
Journal:  Acta Derm Venereol       Date:  1977       Impact factor: 4.437

7.  An immunogenetic basis for the tissue involvement in Behçet's syndrome.

Authors:  T Lehner; J R Batchelor; S J Challacombe; L Kennedy
Journal:  Immunology       Date:  1979-08       Impact factor: 7.397

8.  HLA antigens in recurrent oral ulceration.

Authors:  S J Challacombe; J R Batchelor; L A Kennedy; T Lehner
Journal:  Arch Dermatol       Date:  1977-12

9.  The high prevalence of HLA-B5 in Behçet's disease.

Authors:  H Yazici; G Akokan; B Yalçin; A Müftüoğlu
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

10.  Suppression of leukocyte chemotaxis by human IgA myeloma components.

Authors:  D E Van Epps; R C Williams
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  13 in total

1.  HLA and Behçet's disease in northern Spain: their lack of correlation with arthritis pattern.

Authors:  J Sanchez Burson; J Graña Gil; M Rosales Rodriguez; A Atanes Sandoval; C Alonso Blanco; F Galdo Fernandez
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

2.  PET and MR imaging in a neuro-Behçet syndrome.

Authors:  K Wildhagen; G J Meyer; G Stoppe; P Heintz; H Deicher; H Hundeshagen
Journal:  Eur J Nucl Med       Date:  1989

3.  Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapy.

Authors:  M L Pacor; D Biasi; C Lunardi; P Cortina; P Caramaschi; D Girelli; M Botto; G Urbani; G Lombardo; L M Bambara
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

4.  HLA antigen familial study in complete Behçet's syndrome affecting three sisters.

Authors:  J L Villanueva; J Gonzalez-Dominguez; R Gonzalez-Fernandez; J L Prada; J Peña; R Solana
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

Review 5.  HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies.

Authors:  Mathilde de Menthon; Michael P Lavalley; Carla Maldini; Loïc Guillevin; Alfred Mahr
Journal:  Arthritis Rheum       Date:  2009-10-15

6.  HLA antigens in a Japanese family with Behçet's disease.

Authors:  S Hayasaka; H Kurome; S Noda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-10       Impact factor: 3.117

7.  Animal Models in Behçet's Disease.

Authors:  Ozlem Yildirim
Journal:  Patholog Res Int       Date:  2012-02-27

8.  Behcet's disease and cardiovascular involvement: our experience of asymptomatic Behcet's patients.

Authors:  Zeynep Ulusan; Ayse Serap Karadag; Mehmet Tasar; Mehmet Kalender; Osman Tansel Darcin
Journal:  Cardiovasc J Afr       Date:  2014 Mar-Apr       Impact factor: 1.167

Review 9.  Etiopathogenesis of recurrent aphthous stomatitis and the role of immunologic aspects: literature review.

Authors:  Zuzanna Slebioda; Elżbieta Szponar; Anna Kowalska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-11-12       Impact factor: 4.291

Review 10.  Recurrent aphthous stomatitis: genetic aspects of etiology.

Authors:  Zuzanna Slebioda; Elżbieta Szponar; Anna Kowalska
Journal:  Postepy Dermatol Alergol       Date:  2013-04-12       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.